
The prospective study analyzed 115 patients and found that geneMDD influenced genetic classification, confirmed pulmonary diagnoses, and led to treatment changes in 30 cases. Reclassification of variants impacted clinical decisions, emphasizing the role of genetic expertise in FPF care. Whole genome sequencing yielded limited additional findings.
Like
Save
Share